Two Distinct Low-pH Steps Promote Entry of Vaccinia Virus
- 15 August 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (16) , 8613-8620
- https://doi.org/10.1128/jvi.00606-07
Abstract
Entry of vaccinia virus into cells occurs by an endosomal route as well as through the plasma membrane. Evidence for an endosomal pathway was based on findings that treatment at a pH of <6 of mature virions attached to the plasma membrane enhances entry, whereas inhibitors of endosomal acidification reduce entry. Inactivation of infectivity by low-pH treatment of virions prior to membrane attachment is characteristic of many viruses that use the endosomal route. Nevertheless, we show here that the exposure of unattached vaccinia virus virions to low pH at 37 degrees C did not alter their infectivity. Instead, such treatment stably activated virions as indicated by their accelerated entry upon subsequent addition to cells, as measured by reporter gene expression. Moreover, the rate of entry was not further enhanced by a second low-pH treatment following adsorption to the plasma membrane. However, the entry of virions activated prior to adsorption remained sensitive to inhibitors of endosomal acidification, whereas virions treated with low pH after adsorption were resistant. Activation of virions by low pH was closely mimicked by proteinase digestion, suggesting that the two treatments operate through a related mechanism. Although proteinase cleavage of the virion surface proteins D8 and A27 correlated with activation, mutant viruses constructed by individually deleting these genes did not exhibit an activated phenotype. We propose a two-step model of vaccinia virus entry through endosomes, in which activating or unmasking the fusion complex by low pH or by proteinase is rate limiting but does not eliminate a second low-pH step mediating membrane fusion.Keywords
This publication has 45 references indexed in Scilit:
- Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion ComplexJournal of Virology, 2007
- Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 ProteinJournal of Virology, 2006
- Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal PathwayJournal of Virology, 2006
- The Envelope G3L Protein Is Essential for Entry of Vaccinia Virus into Host CellsJournal of Virology, 2006
- Ligand-induced and nonfusogenic dissolution of a viral membraneProceedings of the National Academy of Sciences, 2006
- The Product of the Vaccinia Virus L5R Gene Is a Fourth Membrane Protein Encoded by All Poxviruses That Is Required for Cell Entry and Cell-Cell FusionJournal of Virology, 2005
- Vaccinia Virus H2 Protein Is an Essential Component of a Complex Involved in Virus Entry and Cell-Cell FusionJournal of Virology, 2005
- Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L GeneJournal of Virology, 2004
- Preparation of Cell Cultures and Vaccinia Virus StocksCurrent Protocols in Molecular Biology, 1998
- Influenza Hemagglutinin-Mediated Membrane Fusion: Influence of Receptor Binding on the Lag Phase Preceding FusionBiochemistry, 1995